Extended Injection Intervals after Switching from Ranibizumab to Aflibercept in Macular Edema due to Central Retinal Vein Occlusion

Purpose. To assess treatment interval extension after switching from ranibizumab to aflibercept intravitreal injections in macular edema (ME) due to central retinal vein occlusion (CRVO) with an insufficient response or frequent recurrences to initial treatment. Methods. CRVO eyes treated with ranib...

Full description

Saved in:
Bibliographic Details
Main Authors: Sylvia Nghiem-Buffet, Agnès Glacet-Bernard, Manar Addou-Regnard, Eric H. Souied, Salomon Y. Cohen, Audrey Giocanti-Auregan
Format: Article
Language:English
Published: Wiley 2018-01-01
Series:Journal of Ophthalmology
Online Access:http://dx.doi.org/10.1155/2018/8656495
Tags: Add Tag
No Tags, Be the first to tag this record!